Header cover image

U.K. (FTSE) Healthtech Industry Analysis

UpdatedMay 21, 2025
DataAggregated Company Financials
Companies8
  • 7D10.1%
  • 3M6.7%
  • 1Y-4.0%
  • YTDn/a

Over the last 7 days, the Healthtech industry has risen 12%, driven by gains from Craneware of 14%. In contrast, the industry has lost 3.4% in the last 12 months. Looking forward, earnings are forecast to grow by 43% annually.

Industry Valuation and Performance

Has the U.K. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 21 May 2025UK£979.5mUK£281.3m-UK£3,795,730.5069.7x-258.1x3.5x
Fri, 18 Apr 2025UK£741.3mUK£285.4m-UK£3,496,534.5048.9x-212x2.6x
Sun, 16 Mar 2025UK£865.0mUK£289.2m-UK£3,209,595.7557.2x-269.5x3x
Tue, 11 Feb 2025UK£908.3mUK£304.1m-UK£8,641,474.2570.3x-105.1x3x
Thu, 09 Jan 2025UK£958.4mUK£298.9m-UK£8,858,605.9379.6x-108.2x3.2x
Sat, 07 Dec 2024UK£1.0bUK£300.4m-UK£8,736,605.4587.7x-115.3x3.4x
Mon, 04 Nov 2024UK£908.5mUK£299.1m-UK£4,028,319.1542.7x-225.5x3x
Wed, 02 Oct 2024UK£749.2mUK£184.2m-UK£3,190,614.0343x-234.8x4.1x
Fri, 30 Aug 2024UK£829.4mUK£178.8m-UK£4,890,617.0858.8x-169.6x4.6x
Sun, 28 Jul 2024UK£908.3mUK£183.5m-UK£6,095,533.0062.9x-149x4.9x
Tue, 25 Jun 2024UK£879.8mUK£183.8m-UK£16,918,225.0860.4x-52x4.8x
Thu, 23 May 2024UK£845.1mUK£182.7m-UK£17,166,638.6058.1x-49.2x4.6x
Sat, 20 Apr 2024UK£867.0mUK£184.9m-UK£17,466,757.0857.7x-49.6x4.7x
Mon, 18 Mar 2024UK£882.4mUK£178.1m-UK£17,720,458.80107.5x-49.8x5x
Wed, 14 Feb 2024UK£803.8mUK£174.7m-UK£17,169,858.5298.3x-46.8x4.6x
Fri, 12 Jan 2024UK£2.1bUK£419.1m-UK£18,287,272.0059.8x-117.2x5.1x
Sun, 10 Dec 2023UK£2.1bUK£421.4m-UK£18,164,948.0059.8x-115.6x5x
Tue, 07 Nov 2023UK£2.1bUK£427.0m-UK£57,291,293.0057x-37.4x5x
Thu, 05 Oct 2023UK£2.1bUK£429.8m-UK£57,868,928.0056.5x-36.3x4.9x
Sat, 02 Sep 2023UK£2.1bUK£417.4m-UK£44,706,457.0040.2x-47x5x
Mon, 31 Jul 2023UK£1.7bUK£411.9m-UK£34,691,595.0029.9x-50.3x4.2x
Wed, 28 Jun 2023UK£1.7bUK£413.2m-UK£34,926,219.0030.5x-48.6x4.1x
Fri, 26 May 2023UK£1.7bUK£412.8m-UK£44,126,113.0050x-37.7x4x
Sun, 23 Apr 2023UK£1.8bUK£406.9m-UK£46,808,076.0064.4x-38x4.4x
Tue, 21 Mar 2023UK£2.0bUK£408.3m-UK£48,642,303.0071.3x-40.5x4.8x
Thu, 16 Feb 2023UK£2.1bUK£407.4m-UK£48,617,123.0073.4x-43.2x5.2x
Sat, 14 Jan 2023UK£2.2bUK£405.1m-UK£47,890,481.0082.6x-45.5x5.4x
Mon, 12 Dec 2022UK£2.2bUK£403.9m-UK£47,618,940.0087.5x-46.8x5.5x
Wed, 09 Nov 2022UK£2.2bUK£408.6m-UK£51,417,709.0079x-42.6x5.4x
Fri, 07 Oct 2022UK£2.1bUK£411.9m-UK£56,366,577.0071x-37.2x5.1x
Sun, 04 Sep 2022UK£2.1bUK£352.3m-UK£54,494,349.0080.1x-38.7x6x
Tue, 02 Aug 2022UK£2.2bUK£344.1m-UK£53,342,518.0091.4x-41.4x6.4x
Thu, 30 Jun 2022UK£2.3bUK£345.2m-UK£48,593,702.0085.2x-47.2x6.6x
Sat, 28 May 2022UK£1.7bUK£341.3m-UK£47,481,896.0080.2x-36.3x5x
Price to Earnings Ratio

-36.3x


Total Market Cap: UK£1.7bTotal Earnings: -UK£47,481,896.00Total Revenue: UK£341.3mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthtech Industry Price to Earnings3Y Average -94.1x202320242025
Current Industry PE
  • Investors are pessimistic on the British Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Health Care Technology industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 6.3% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does U.K. Healthtech compare with similar industries?

GB Market2.11%
Healthcare2.92%
Healthtech10.15%
Healthtech10.15%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRW CranewareUK£22.1013.9%
+UK£94.6m
0.9%PE69.7x
RENX RenalytixUK£0.0853.0%
+UK£828.0k
-60.5%PS13x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CRW

UK£22.10

Craneware

7D

13.9%

1Y

0.9%

COG

UK£0.37

Cambridge Cognition Holdings

7D

-1.3%

1Y

-17.8%

OPT

UK£1.93

Optima Health

7D

-2.3%

1Y

n/a

INHC

UK£0.095

Induction Healthcare Group

7D

-1.0%

1Y

-24.0%

RENX

UK£0.085

Renalytix

7D

3.0%

1Y

-60.5%